Susana
Ravassa Albéniz
Profesional Investigadora
Francisco Javier
Beaumont Ezcurra
Investigador Asociado
Publications dans lesquelles il/elle collabore avec Francisco Javier Beaumont Ezcurra (31)
2021
-
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498
2020
-
Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Scientific Reports, (2017), 7, 1, (40696), 10.1038/srep40696)
Scientific Reports
-
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action
Nefrologia, Vol. 40, Núm. 3, pp. 223-236
-
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
Circulation, Vol. 141, Núm. 9, pp. 751-767
2017
-
Hypertensive Heart Disease
Encyclopedia of Cardiovascular Research and Medicine (Elsevier), pp. 517-526
-
Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites
Scientific Reports, Vol. 7
-
MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure
Scientific Reports, Vol. 7
-
The Hypertensive Myocardium: From Microscopic Lesions to Clinical Complications and Outcomes
Medical Clinics of North America, Vol. 101, Núm. 1, pp. 43-52
2016
-
Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure
Journal of the American College of Cardiology, Vol. 67, Núm. 3, pp. 251-260
-
Potential role of microRNA-10b down-regulation in cardiomyocyte apoptosis in aortic stenosis patients
Clinical Science, Vol. 130, Núm. 23, pp. 2139-2149
2015
-
Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: A pilot study
Free Radical Biology and Medicine, Vol. 81, pp. 1-12
-
Circulating biomarkers of myocardial fibrosis: The need for a reappraisal
Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2449-2456
2013
-
Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients
Journal of Hypertension, Vol. 31, Núm. 3, pp. 587-594
-
Osteopontin-mediated myocardial fibrosis in heart failure: A role for lysyl oxidase?
Cardiovascular Research, Vol. 99, Núm. 1, pp. 111-120
2012
-
Cardiotrophin-1 in hypertensive heart disease
Endocrine, Vol. 42, Núm. 1, pp. 9-17
-
Contribution of circulating biomarkers to unravel the role of extracellular matrix in hypertensive cardiac remodelling
Journal of Hypertension
2011
-
New targets to treat the structural remodeling of the myocardium
Journal of the American College of Cardiology, Vol. 58, Núm. 18, pp. 1833-1843
-
Towards the molecular diagnosis of hypertensive heart disease?
Journal of Hypertension, Vol. 29, Núm. 4, pp. 660-662
2010
-
Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5
Cardiovascular Research, Vol. 88, Núm. 2, pp. 304-313
2009
-
Biochemical markers of myocardial remodelling in hypertensive heart disease
Cardiovascular Research, Vol. 81, Núm. 3, pp. 509-518